Development of novel HER2 inhibitors against gastric cancer derived from flavonoid source of Syzygium alternifolium through molecular dynamics and pharmacophore-based screening
Tirumalasetty Muni Chandra Babu,1 Aluru Rammohan,2 Vijaya Bhaskar Baki,1 Savita Devi,3 Duvvuru Gunasekar,2 Wudayagiri Rajendra1 1Bioinformatics Center, Division of Molecular Biology, Department of Zoology, 2Natural Products Division, Department of Chemistry, Sri Venkateswara University, Tirupati, A...
Main Authors: | Babu TMC, Rammohan A, Baki VB, Devi S, Gunasekar D, Rajendra W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-11-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/development-of-novel-her2-inhibitors-against-gastric-cancer-derived-fr-peer-reviewed-article-DDDT |
Similar Items
-
Combined Pharmacophore Modeling, Docking, and 3D-QSAR Studies of PLK1 Inhibitors
by: Tao Lu, et al.
Published: (2011-12-01) -
Structure-Based Pharmacophore Design and Virtual Screening for Novel Tubulin Inhibitors with Potential Anticancer Activity
by: Yunjiang Zhou, et al.
Published: (2019-09-01) -
Identification of New Potential APE1 Inhibitors by Pharmacophore Modeling and Molecular Docking
by: In Won Lee, et al.
Published: (2017-12-01) -
Identification of Novel Src Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations
by: Yi Zhang, et al.
Published: (2020-09-01) -
Identification of Phosphatidylinositol 3-kinase δ (PI3Kδ) Inhibitor: Pharmacophore-based Virtual Screening and Molecular Dynamics Simulation
by: Muhammad Arba, et al.
Published: (2020-07-01)